Field Guide · The Honest Read
IVIG is a serious, expensive immune therapy — and in autism, the honest line matters. It is not a treatment for autism itself. Where it can help is a narrow, immune-driven subset: a child with a real immunodeficiency, or a PANS-type autoimmune flare on top of autism. Here’s how to tell the difference, what the limited evidence shows, and why the distinction protects your child.
This is a heavy intervention with a real cost and real risk. We’d rather narrow it to the children it can actually help than widen it with false hope.
IVIG is not a treatment for autism itself, and the evidence doesn’t support using it that way. It may help a narrow, immune-driven subset — a documented immunodeficiency, or a PANS / autoimmune-encephalitis overlap — where there’s an actual immune attack for it to calm. Even there the controlled evidence is limited. The immune workup, not the autism label, decides whether IVIG has anything to act on. No cure, no recovery promise.
IVIG = intravenous immunoglobulin — concentrated antibodies pooled from thousands of donors, given by infusion. In this context it isn’t fighting an infection; it’s an immunomodulator that helps calm and re-regulate an immune system that has turned on the brain (the autoantibody / neuroinflammation picture).
That tells you immediately where IVIG can and can’t do anything. If there’s a genuine immune attack on the brain, IVIG has a target. If the picture is core neurodevelopmental autism with no immune driver, there is little for it to act on — which is exactly why “IVIG for autism” as a blanket idea doesn’t hold up. For the full deconstruction — who qualifies, infusion day, side effects, the studies — see the main IVIG explainer.
Autistic children are at higher risk for PANS-type immune flares, not lower — and some carry real, treatable immune findings. These are the situations where IVIG has a coherent rationale:
A child with low IgG / hypogammaglobulinemia or specific antibody deficiency (SPAD) — an immune system that can’t mount or hold a normal response, so infections keep re-triggering them. Here IVIG does double duty: it replaces the antibodies and modulates the immune system. This is also the diagnosis that makes IVIG insurance-coverable.
An autistic child who develops an abrupt regression, new OCD or rage, or a clear autoimmune-encephalitis picture — an immune attack layered on top of their baseline. When the driver really is autoantibody-mediated brain inflammation, IVIG can calm that attack, and the inflammatory layer can ease. This is the PANS case, not the autism case. See the full PANS treatment map.
Core autism with no immune driver. If the immune workup is clean and there’s no autoimmune or deficiency picture, IVIG has little to act on — and subjecting a child to a heavy, costly, risk-carrying infusion on the hope it changes autism itself is not supported by the evidence. The workup decides, not the diagnosis label.
Is there a real immune driver under your child’s picture — and which labs would show it? Plan B reads your child’s symptoms, history, and any labs together and tells you honestly whether IVIG even belongs on your table, and what immune workup would answer the question. Your first Synthesis is free.
Start your free Synthesis → Parent education, not medical advice. No cure claims. You stay in charge.Before IVIG is even a conversation, the immune workup tells you whether there’s a driver — and it’s the same workup that gets IVIG covered if there is:
The clean way to think about it: if the workup shows a real immune driver, IVIG is worth a serious conversation — billed and justified under immunodeficiency. If it doesn’t, that’s your answer too, and it saves your child from a heavy intervention that wouldn’t have a target. For the access and insurance mechanics, see how to get IVIG covered.
IVIG is not a treatment for autism itself, and the evidence doesn’t support using it that way. It can be the right tool for a narrow, immune-driven subset — a documented immunodeficiency, or a PANS / autoimmune-encephalitis overlap — where there’s an actual immune attack to calm. Even then the controlled evidence is limited, and it is not a cure. Let the immune workup decide: it tells you whether IVIG has a target, and it’s the same thing that gets it covered. This is parent education, not medical advice — bring it to your team as questions.
Plan B does not partner with drug companies or doctors, and we never endorse anyone whose healing isn’t verified by families. We show you the options and how to vet them yourself — and we’re building parent verification: look up a clinic or practitioner and see real family reviews before you trust them. Universal bad reviews? Skip.